United Kingdom· GB-APID-10238211000001102
Cytomegalovirus immunoglobulin human 3g powder for solution for infusion vials
A cytomegalovirus immunoglobulin product containing cytomegalovirus immunoglobulin, registered in United Kingdom by Scottish National Blood Transfusion Service. The same ATC class is registered in 9 of our 19 countries.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
Where it is registered
Cytomegalovirus immunoglobulin is registered in 9 of 19 countries.
Countries holding a registration under ATC J06BB09 (cytomegalovirus immunoglobulin), each read from that country’s own register.
- This record: United Kingdom, from NHS dm+d (United Kingdom)
- 5 of them publish a price we can compare per daily dose
Cytomegalovirus immunoglobulin · ATC J06BB09
9 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Finlandprice
- Ireland
- Netherlands
- Polandprice
- Switzerlandprice
- United Kingdom
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Cytomegalovirus immunoglobulin
- Manufacturer
- Scottish National Blood Transfusion Service
- Country
- United Kingdom (GB)
- ATC code
- J06BB09
- ATC class
- Cytomegalovirus immunoglobulin
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Cytomegalovirus immunoglobulin in 7 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- BelgiumIvegam-CMV 100 mg/mlCentrale Afdeling Voor Fractionering - Departement Central De Fractionnement
- GermanyCytotect CpBiotest Pharma Gmbh
- SpainMEGALOTECT 100 U/ML SOLUCION PARA PERFUSIONBiotest Pharma Gmbh
- CanadaCYTOGAMKI BIOPHARMA LLC
- IrelandMegalotect 100 U/mL solution for infusionBiotest Pharma GmbH
- NetherlandsMegalotect 100 E/ml oplossing voor infusieBiotest Pharma GmbH
- PolandMegalotect CPBiotest Pharma GmbH
Authorised across Europe · EMA
The same active substance is authorised in 17 EEA countries. Names it is sold under:
- Austria · Cytotect Cp
- Belgium · Megalotect
- Czechia · Cymvigo
- Germany · Cytotect Cp
- Spain · Megalotect
- Greece · Megalotect Cp
- Croatia · Cytotect Cp
- Hungary · Cytotect Cp
- Ireland · Megalotect
- Italy · Cytomegatect
- Lithuania · Cymvigo
- Netherlands · Megalotect
- Poland · Megalotect Cp
- Portugal · Megalotect Cp
- Romania · Cytotect Cp
- Slovenia · Megalotect
- Slovakia · Cytotect
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/813aee6e-43ee-4275-87f5-86f670c09f11 GET /v1/drugs/813aee6e-43ee-4275-87f5-86f670c09f11?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "10238211000001102",
"desc": "Cytomegalovirus immunoglobulin human 3g powder for solution for infusion vials (Scottish National Blood Transfusion Service)",
"form": "Powder for solution for infusion",
"vpid": "10238011000001107",
"source": "dmd",
"vtm_id": "775430003",
"strength": "3 gram",
"substance": "Cytomegalovirus immunoglobulin",
"ingredient": "Cytomegalovirus immunoglobulin human",
"supplier_code": "2093601000001101"
}See everything about cytomegalovirus immunoglobulin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.